Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision MedicineREAD THE PR

Proscia’s Concentriq Dx Attains CE Mark Under IVDR For Use In Primary Diagnosis

Proscia
By Author Proscia | June 8, 2022

Concentriq Dx is the platform of choice for top reference laboratories and health systems in Europe, including LabPON and Uppsala University Hospital.

Our website uses cookies. By using this site, you agree to its use of cookies.